Dr. Abdulrazaq S. Al-Jazairi is a Consultant Clinical Pharmacist specializing in Cardiovascular Pharmacotherapy and serves as Director of the Clinical Trials Transformation Division at King Faisal Specialist Hospital & Research Centre in Riyadh. He is also the Lead Founder of the Saudi Society of Clinical Pharmacy.
He earned his Doctor of Pharmacy degree from Campbell University, followed by postgraduate training at Duke University Medical Center and a specialty residency in Cardiovascular Pharmacotherapy at the University of the Sciences in Philadelphia in conjunction with the Hospital University of Pennsylvania. He later completed a Master’s degree in Pharmaceutical and Healthcare Business.
Dr. Al-Jazairi is a board-certified pharmacotherapy specialist with a Cardiology added-qualification. He has authored more than 50 original research publications, delivered numerous national and international presentations, and contributes extensively to clinical research, evidence-based medicine, education and professional pharmacy development.